Back
Xeris Biopharma Holdings Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
70
XERS
Xeris Biopharma Holdings
Last Price:
$3.48
Seasonality Move:
-18.08%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.Xeris Biopharma Holdings Stock Forecast
-
Is Xeris Biopharma Holdings Stock Undervalued?The current Xeris Biopharma Holdings [XERS] share price is $3.47. The Score for XERS is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
XERS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Xeris Biopharma Holdings Stock Go Up Next Year?
Data Unavailable
Xeris Biopharma Holdings Stock Rating
Data Unavailable
Xeris Biopharma Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
xerispharma.com
52-Week Data
52-Week High:
3.87
52-Week Low:
1.69
Prediction Charts
Market Cap:
517.3M
Price in USD:
3.47
Volume:
520.7K
Beta:
1.45
Technical Analysis
SMA50:
3.26
SMA100:
3.00
SMA200:
2.56
52-Wk Change:
66.03%
Stock Predictions
-
Is Xeris Biopharma Holdings stock public?Yes, Xeris Biopharma Holdings is a publicly traded company.
-
What is the Xeris Biopharma Holdings stock quote today?The Xeris Biopharma Holdings stock price is 3.47 USD today.
-
How to buy Xeris Biopharma Holdings stock online?You can buy Xeris Biopharma Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 3.57 | 3.73 | 3.76 | 3.54 |
| Dec-6 | 3.71 | 3.67 | 3.87 | 3.67 |
| Dec-9 | 3.69 | 3.61 | 3.75 | 3.59 |
| Dec-10 | 3.61 | 3.58 | 3.74 | 3.57 |
| Dec-11 | 3.59 | 3.51 | 3.59 | 3.46 |
| Dec-12 | 3.48 | 3.40 | 3.63 | 3.38 |
| Dec-13 | 3.39 | 3.28 | 3.46 | 3.26 |
| Dec-16 | 3.28 | 3.37 | 3.46 | 3.27 |
| Dec-17 | 3.38 | 3.41 | 3.46 | 3.35 |
| Dec-18 | 3.43 | 3.25 | 3.43 | 3.17 |
| Dec-19 | 3.30 | 3.41 | 3.44 | 3.27 |
| Dec-20 | 3.35 | 3.49 | 3.57 | 3.35 |
| Dec-23 | 3.47 | 3.42 | 3.48 | 3.32 |
| Dec-24 | 3.42 | 3.47 | 3.52 | 3.41 |
Xeris Biopharma Holdings Earnings
Data Unavailable
Xeris Biopharma Holdings Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.05 per share.
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.